Authors
D.O. Roberts
Vanderbilt University, Department of Pediatric Sickle Cell Disease, Nashville, TN, USA
B. Covert
Vanderbilt University, Department of Pediatric Sickle Cell Disease, Nashville, TN, USA
T. Lindsey
Sickle Cell Disease Nurse Practitioner, Missouri Newborn Screening Coordinator, Washington University School of Medicine, St. Louis, MO, USA
V. Edwards
Biomedical Services, American Red Cross, St. Louis, MO, USA
L. McLaughlin
American Red Cross, Biomedical Headquarters, Holland Laboratory, Rockville, MD, USA
J. Theus
South Central Division, American Red Cross, Little Rock, AR, USA
R.J. Wray
Community Health, Little Rock, AR, USA
K. Jupka
Saint Louis University School of Public Health, St. Louis, MO, USA
D. Baker
Medical Technologist Laboratory, BJC St. Louis Children’s Hospital, St. Louis, MO, USA
M. Robbins
Medical Technologist Laboratory, BJC St. Louis Children’s Hospital, St. Louis, MO, USA
M.R. DeBaun
Pediatrics and Medicine, JC Peterson Endowed Chair in Pediatrics, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Monroe Carell Jr. Children’s Hospital at Vanderbilt University, Nashville, TN, USA